CD4 and COVID-19: However, analysis of single-cell RNA sequencing datasets obtained from bronchioalveolar fluid (BALF) and PBMC samples of COVID-19 patients demonstrated that the activation of the inflammasome pathway occurs in monocytes and macrophages but not in other immune cells including B-cells, CD4+ and CD8+ T-cells or natural killer cells [34, 35].